Head-to-Head

Aktis Oncology, Inc. Common stock vs. Eli Lilly & Co.

AKTS

Aktis Oncology, Inc. Common stock

$24.93 +4.79%

VS LLY

Eli Lilly & Co.

$1209.00 -0.92%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AKTSLLY
Market Cap $1.33 billion $1.09 trillion

LLY leads on 1 of 1 size & scale factors.

Valuation

AKTSLLY
Price / Book 2.62 —

AKTS and LLY split the valuation factors evenly.

Risk & Sentiment

AKTSLLY
Short Interest 1.68% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: AKTS overview, AKTS financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.